|
| 36787739 | Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding. | Am J Hum Genet | 2023 |
| 37843857 | Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial. | Clin Cancer Res | 2023 |
| 37595489 | Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial. | Eur J Cancer | 2023 |
| 37334316 | Effect of Radiotherapy Dose on Outcome in Nonmetastatic Ewing Sarcoma. | Adv Radiat Oncol | 2023 |
| 37046711 | Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. | Cancers (Basel) | 2023 |
| 37364231 | Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM. | JCO Precis Oncol | 2023 |
| 37106651 | Evaluation of the Effect of Photodynamic Therapy on CAM-Grown Sarcomas. | Bioengineering (Basel) | 2023 |
| 36787739 | Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding. | Am J Hum Genet | 2023 |
| 37595489 | Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial. | Eur J Cancer | 2023 |
| 37843857 | Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial. | Clin Cancer Res | 2023 |
| 37046711 | Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. | Cancers (Basel) | 2023 |
| 37106651 | Evaluation of the Effect of Photodynamic Therapy on CAM-Grown Sarcomas. | Bioengineering (Basel) | 2023 |
| 37334316 | Effect of Radiotherapy Dose on Outcome in Nonmetastatic Ewing Sarcoma. | Adv Radiat Oncol | 2023 |
| 37364231 | Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM. | JCO Precis Oncol | 2023 |
| 35195899 | Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults. | Cancer | 2022 |
| 36230742 | Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma. | Cancers (Basel) | 2022 |
| 36291967 | Utility of Integrated PET/MRI for the Primary Diagnostic Work-Up of Patients with Ewing Sarcoma: Preliminary Results. | Diagnostics (Basel) | 2022 |
| 36290890 | Effects of an Exercise Intervention on Gait Function in Young Survivors of Osteosarcoma with Megaendoprosthesis of the Lower Extremity-Results from the Pilot Randomized Controlled Trial proGAIT. | Curr Oncol | 2022 |
| 36073842 | Multidisciplinary Network ActiveOncoKids guidelines for providing movement and exercise in pediatric oncology: Consensus-based recommendations. | Pediatr Blood Cancer | 2022 |
| 35427190 | High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma. | J Clin Oncol | 2022 |
| 35802025 | FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits. | Cancer Res | 2022 |
| 36202860 | Small round cell sarcomas. | Nat Rev Dis Primers | 2022 |
| 35672690 | Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial). | BMC Cancer | 2022 |
| 36575299 | Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM. | NPJ Precis Oncol | 2022 |
| 36497417 | Ewing Sarcoma as Secondary Malignant Neoplasm-Epidemiological and Clinical Analysis of an International Trial Registry. | Cancers (Basel) | 2022 |
| 36497401 | Secondary Malignancies after Ewing Sarcoma-Epidemiological and Clinical Analysis of an International Trial Registry. | Cancers (Basel) | 2022 |
| 33931468 | <sup>68</sup>Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the <sup>68</sup>Ga-FAPI PET Prospective Observational Trial. | J Nucl Med | 2022 |
| 34980141 | Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma. | Mol Cancer | 2022 |
| 35251976 | Proton Therapy for Primary Bone Malignancy of the Pelvic and Lumbar Region - Data From the Prospective Registries ProReg and KiProReg. | Front Oncol | 2022 |
| 35033148 | 5-ALA-mediated fluorescence of musculoskeletal tumors in a chick chorio-allantoic membrane model: preclinical in vivo qualification analysis as a fluorescence-guided surgery agent in Orthopedic Oncology. | J Orthop Surg Res | 2022 |
| 35204913 | Etiology, Risk Factors, and Diagnosis of Back Pain in Children and Adolescents: Evidence- and Consensus-Based Interdisciplinary Recommendations. | Children (Basel) | 2022 |
| 35327789 | Treatment of Unspecific Back Pain in Children and Adolescents: Results of an Evidence-Based Interdisciplinary Guideline. | Children (Basel) | 2022 |
| 35195899 | Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults. | Cancer | 2022 |
| 35802025 | FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits. | Cancer Res | 2022 |
| 35672690 | Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial). | BMC Cancer | 2022 |
| 35427190 | High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma. | J Clin Oncol | 2022 |
| 36575299 | Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM. | NPJ Precis Oncol | 2022 |
| 36497417 | Ewing Sarcoma as Secondary Malignant Neoplasm-Epidemiological and Clinical Analysis of an International Trial Registry. | Cancers (Basel) | 2022 |
| 36497401 | Secondary Malignancies after Ewing Sarcoma-Epidemiological and Clinical Analysis of an International Trial Registry. | Cancers (Basel) | 2022 |
| 36073842 | Multidisciplinary Network ActiveOncoKids guidelines for providing movement and exercise in pediatric oncology: Consensus-based recommendations. | Pediatr Blood Cancer | 2022 |
| 36202860 | Small round cell sarcomas. | Nat Rev Dis Primers | 2022 |
| 36230742 | Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma. | Cancers (Basel) | 2022 |
| 36291967 | Utility of Integrated PET/MRI for the Primary Diagnostic Work-Up of Patients with Ewing Sarcoma: Preliminary Results. | Diagnostics (Basel) | 2022 |
| 36290890 | Effects of an Exercise Intervention on Gait Function in Young Survivors of Osteosarcoma with Megaendoprosthesis of the Lower Extremity-Results from the Pilot Randomized Controlled Trial proGAIT. | Curr Oncol | 2022 |
| 33931468 | <sup>68</sup>Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the <sup>68</sup>Ga-FAPI PET Prospective Observational Trial. | J Nucl Med | 2022 |
| 35251976 | Proton Therapy for Primary Bone Malignancy of the Pelvic and Lumbar Region - Data From the Prospective Registries ProReg and KiProReg. | Front Oncol | 2022 |
| 34980141 | Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma. | Mol Cancer | 2022 |
| 35033148 | 5-ALA-mediated fluorescence of musculoskeletal tumors in a chick chorio-allantoic membrane model: preclinical in vivo qualification analysis as a fluorescence-guided surgery agent in Orthopedic Oncology. | J Orthop Surg Res | 2022 |
| 35204913 | Etiology, Risk Factors, and Diagnosis of Back Pain in Children and Adolescents: Evidence- and Consensus-Based Interdisciplinary Recommendations. | Children (Basel) | 2022 |
| 35327789 | Treatment of Unspecific Back Pain in Children and Adolescents: Results of an Evidence-Based Interdisciplinary Guideline. | Children (Basel) | 2022 |